_
Alzheimer's cure: World General Media News Headlines
Alzheimer's treatment: World General Media News Headlines
Alzheimer theories: World General Media News Headlines
Alzheimer science professional news: Alzforum News & Views
February 03, 2005
MetLife honors Alzheimer's Research
"MetLife Foundation Recognizes Scientists for Research in Alzheimer's Disease " (2 February 2005, Business Wire)
Excerpt: "The MetLife Foundation Awards for Medical Research in Alzheimer's Disease were presented in Washington, D.C. today to William E. Klunk, M.D., Ph.D. and Chester A. Mathis, Ph.D., of the University of Pittsburgh School of Medicine; John C. Morris, M.D., of the Washington University School of Medicine in St. Louis, and Ronald C. Petersen, M.D., Ph.D., of Mayo Clinic. The awards recognized the scientists for their clinical research on early detection and diagnosis of Alzheimer's disease (AD). $700,000 was shared by the winners to further work in AD research. Established in 1986, the Awards recognize scientists who have made significant contributions to the understanding and treatment of Alzheimer's disease. At the heart of the program is a belief in the importance of basic research, with an emphasis on providing scientists with an opportunity to liberally pursue ideas. "Alzheimer's is an issue of national importance. It is also a personal issue for many families, as the disease robs them of the person they once knew," said Robert H. Benmosche, Chairman and CEO of MetLife, Inc. "The impact of Alzheimer's on families, society, and the economy is the reason MetLife is committed to the search for a cure." Today, 4.5 million Americans have Alzheimer's disease. This number is expected to increase dramatically, as millions in the baby-boom generation approach age 65, which is the age of greatest risk for the disease. The brain disorder strikes an estimated one in ten people aged 65 and older and 50 percent of those 85 or older, and is the eighth leading cause of death in the U.S. Without a cure, the Alzheimer's Association estimates that between 11 million and 16 million Americans will have AD by 2050..." [FullText]
Excerpt: "The MetLife Foundation Awards for Medical Research in Alzheimer's Disease were presented in Washington, D.C. today to William E. Klunk, M.D., Ph.D. and Chester A. Mathis, Ph.D., of the University of Pittsburgh School of Medicine; John C. Morris, M.D., of the Washington University School of Medicine in St. Louis, and Ronald C. Petersen, M.D., Ph.D., of Mayo Clinic. The awards recognized the scientists for their clinical research on early detection and diagnosis of Alzheimer's disease (AD). $700,000 was shared by the winners to further work in AD research. Established in 1986, the Awards recognize scientists who have made significant contributions to the understanding and treatment of Alzheimer's disease. At the heart of the program is a belief in the importance of basic research, with an emphasis on providing scientists with an opportunity to liberally pursue ideas. "Alzheimer's is an issue of national importance. It is also a personal issue for many families, as the disease robs them of the person they once knew," said Robert H. Benmosche, Chairman and CEO of MetLife, Inc. "The impact of Alzheimer's on families, society, and the economy is the reason MetLife is committed to the search for a cure." Today, 4.5 million Americans have Alzheimer's disease. This number is expected to increase dramatically, as millions in the baby-boom generation approach age 65, which is the age of greatest risk for the disease. The brain disorder strikes an estimated one in ten people aged 65 and older and 50 percent of those 85 or older, and is the eighth leading cause of death in the U.S. Without a cure, the Alzheimer's Association estimates that between 11 million and 16 million Americans will have AD by 2050..." [FullText]
posted by Dr. Koudinov @ 3.2.05
0 comments
Latest PubMed 20 review articles on Alzheimer’s
Latest PubMed 20 research articles on Alzheimer’s amyloid
Latest PubMed 50 research titles on Alzheimer’s
